China-Biotics Appoints Mr. Li Chi Yuen as CFO.

Brings 20-plus Years of Finance Experience to the Company

SHANGHAI, China -- China-Biotics, Inc. (OTCBB:CHBT), one of China's largest producers of probiotic products and food supplements that benefit and improve the microbial balance in the human body, announced that Mr. Li Chi Yuen has been appointed to the position of Chief Financial Officer, effective November 13, 2006.

Mr. Li's career includes over 20 years of finance (both auditing and accounting) experience serving multiple industries. Mr. Li previously served as the Financial Controller at Techwayson Holdings Limited, a company which designs, supplies and integrates automation and controls system. While at Techwayson, Mr. Li helped keep the company in compliance with GEM and main board Listing Rules, helped close a HK$49M acquisition, conducted due diligence for mergers and acquisitions, provided consolidated financial reports to the Board, and was the liason with key stakeholders and fund managers. Prior to Techwayson, Mr. Li was a Finance Manager at Super Worth Contracting Co. Ltd., which is a contractor for turn-key construction projects, where he supported the CFO by providing financial reports for operating, as well as merger and acquisition, related activities. He also managed an accounting staff over 10 people and interacted with auditors, lawyers, tax consultants, and bankers to formalize strategic planning advice. Mr. Li has a Master of Arts in Language and Law from City University of Hong Kong and a Master of Business Administration from Heriot-Watt University. He is a member of the Hong Kong Institute of Certified Public Accountants, The Chartered Institute of Management Accountants, and the Association of Certified Fraud Examiners.

"During an extensive search, we thoroughly reviewed the credentials and industry experience of several qualified candidates generated through numerous sources. Although there were several who were qualified for the position, we concluded that Mr. Li was the right person for the CFO role at this stage of our Company's growth," stated Mr. Song Jin An, China-Biotics' Chairman and Chief Executive Officer. "The broad experience garnished in all aspects of traditional and operating finance, as well as capabilities earned through interfacing with the investment community made him the clear choice for China-Biotics and would like to welcome Mr. Li to our team."

About China-Biotics

Based in Shanghai, China-Biotics is an emerging leader in the research, development, production, marketing and distribution of probiotics products in the People's Republic of China. Probiotics products contain live microbial food supplements which beneficially affect the host by improving its intestinal microbial balance. Currently, the Company produces and distributes proprietary probiotics, which are approved by the Ministry of Health in China and have been tested by the Shanghai Preventive Medicine Research Institute. For more information, visit the Company's website at www.shiningbt.com.

Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company's filings with the Securities and Exchange Commission.